RU93058374ARU93058374/14ARU93058374ARU93058374ARU 93058374 ARU93058374 ARU 93058374ARU 93058374/14 ARU93058374/14 ARU 93058374/14ARU 93058374 ARU93058374 ARU 93058374ARU 93058374 ARU93058374 ARU 93058374A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берк ЖанfiledCriticalБерк Жан
Publication of RU93058374ApublicationCriticalpatent/RU93058374A/en
Изобретение относится к новому применению рибофлавина или витамина В2 для лечения болезней, связанных с вирусами HIV, в лечении герпеса, пигментарного ретинита и малярии. Рибофлавин может соединяться с витамином РР или AZT в лечении болезней, связанных с вирусами HIV. Клинические испытания показывают ремиссию симптомов герпеса и улучшение состояния пациентов, пораженных СПИДом.The invention relates to a new use of riboflavin or vitamin B2 for the treatment of diseases associated with HIV viruses in the treatment of herpes, retinitis pigmentosa and malaria. Riboflavin can combine with vitamin PP or AZT in the treatment of diseases associated with HIV viruses. Clinical trials show remission of herpes symptoms and an improvement in the condition of AIDS-infected patients.
Pharmaceutical composition comprising 3'-deoxythymidine-2'-ene (3'-deoxy-2 ', 3'-didehydrothymidine) for the treatment of patients infected with retrovirus.
Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses